Protara Therapeutics (TARA) Short Interest Ratio & Short Volume → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free TARA Stock Alerts $3.24 +0.24 (+8.00%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Protara Therapeutics Short Interest DataCurrent Short Volume1,030,000 sharesPrevious Short Volume398,300 sharesChange Vs. Previous Month+158.60%Dollar Volume Sold Short$3.07 millionShort Interest Ratio / Days to Cover3.5Last Record DateApril 30, 2024Outstanding Shares20,590,000 sharesPercentage of Shares Shorted5.00%Today's Trading Volume630,731 sharesAverage Trading Volume238,843 sharesToday's Volume Vs. Average264% Short Selling Protara Therapeutics ? Sign up to receive the latest short interest report for Protara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTARA Short Interest Over TimeTARA Days to Cover Over TimeTARA Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Protara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,030,000 shares $3.07 million +158.6%N/A3.5 $2.98 4/15/2024398,300 shares $1.13 million +510.9%4.4%1.6 $2.84 3/31/202465,200 shares $261,452.00 +6.2%0.7%0.3 $4.01 3/15/202461,400 shares $225,952.00 -22.3%0.7%0.8 $3.68 2/29/202479,000 shares $360,240.00 +33.9%0.9%1.1 $4.56 2/15/202459,000 shares $208,270.00 -33.0%0.7%0.8 $3.53 Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202488,100 shares $224,655.00 +19.2%1.1%1.5 $2.55 1/15/202473,900 shares $170,709.00 +1.5%0.9%1.3 $2.31 12/31/202372,800 shares $136,507.28 +46.8%0.9%1.3 $1.88 12/15/202349,600 shares $88,288.00 -16.2%0.6%1.1 $1.78 11/30/202359,200 shares $85,840.00 +22.3%0.7%1.6 $1.45 11/15/202348,400 shares $58,080.00 +1.7%0.6%1.6 $1.20 10/31/202347,600 shares $59,271.52 -3.3%0.6%1.9 $1.25 10/15/202349,200 shares $81,180.00 -4.3%0.6%2.5 $1.65 9/30/202351,400 shares $85,838.00 +5.5%0.6%2.2 $1.67 9/15/202348,700 shares $90,095.00 -7.4%0.6%1.8 $1.85 8/31/202352,600 shares $114,668.00 +14.4%0.6%1.8 $2.18 8/15/202346,000 shares $109,020.00 -40.8%0.6%1.4 $2.37 7/31/202377,700 shares $201,243.00 -28.5%0.9%2.3 $2.59 7/15/2023108,600 shares $298,650.00 +10.0%1.3%2.9 $2.75 6/30/202398,700 shares $235,893.00 -9.0%1.2%2.7 $2.39 6/15/2023108,400 shares $308,940.00 +11.0%1.3%3.2 $2.85 5/31/202397,700 shares $272,583.00 +0.2%1.2%2.7 $2.79 5/15/202397,500 shares $328,575.00 -4.6%1.2%2.6 $3.37 4/30/2023102,200 shares $322,952.00 +34.1%1.2%3.2 $3.16 4/15/202376,200 shares $221,742.00 -0.4%0.9%2.4 $2.91 3/31/202376,500 shares $239,445.00 -0.4%0.9%3.2 $3.13 3/15/202376,800 shares $235,776.00 -0.9%0.9%3.2 $3.07 2/28/202377,500 shares $273,575.00 -5.8%0.9%4.2 $3.53 2/15/202382,300 shares $264,183.00 -2.4%0.9%4.5 $3.21 1/31/202384,300 shares $275,239.50 -0.6%1.0%3.5 $3.27 1/15/202384,800 shares $284,928.00 -1.5%1.0%3.2 $3.36 12/30/202286,100 shares $230,748.00 +8.4%1.0%3 $2.68 12/15/202279,400 shares $243,758.00 -30.8%0.9%2.5 $3.07 11/30/2022114,700 shares $404,891.00 +22.7%1.3%3 $3.53 11/15/202293,500 shares $276,760.00 +7.5%1.0%2.2 $2.96 10/31/202287,000 shares $267,090.00 +2.7%1.0%2 $3.07 10/15/202284,700 shares $281,204.00 -16.6%1.0%2.1 $3.32 9/30/2022101,600 shares $300,736.00 -9.5%1.2%2.8 $2.96 9/15/2022112,200 shares $433,092.00 +14.5%1.3%2.6 $3.86Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now TARA Short Interest - Frequently Asked Questions What is Protara Therapeutics' current short interest? Short interest is the volume of Protara Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,030,000 shares of TARA short. Learn More on Protara Therapeutics' current short interest. What is a good short interest ratio for Protara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARA shares currently have a short interest ratio of 4.0. Learn More on Protara Therapeutics's short interest ratio. Is Protara Therapeutics' short interest increasing or decreasing? Protara Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,030,000 shares, an increase of 158.6% from the previous total of 398,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Protara Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Protara Therapeutics: Achilles Therapeutics plc (0.06%), MiNK Therapeutics, Inc. (0.88%), Surrozen, Inc. (2.15%), Pluri Inc. (0.97%), Estrella Immunopharma, Inc. (0.12%), SAB Biotherapeutics, Inc. (0.30%), Quince Therapeutics, Inc. (6.58%), Brainstorm Cell Therapeutics Inc. (3.07%), OKYO Pharma Limited (0.43%), Dyadic International, Inc. (0.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Protara Therapeutics stock? Short selling TARA is an investing strategy that aims to generate trading profit from Protara Therapeutics as its price is falling. TARA shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Protara Therapeutics? A short squeeze for Protara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TARA, which in turn drives the price of the stock up even further. How often is Protara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ACHL Short Squeeze INKT Short Squeeze SRZN Short Squeeze PLUR Short Squeeze ESLA Short Squeeze SABS Short Squeeze QNCX Short Squeeze BCLI Short Squeeze OKYO Short Squeeze DYAI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsGold ManiaStansberry Research